Production and Manufacturing Sample Clauses

Production and Manufacturing. DWM represents and warrants to West Marine that DWM:
AutoNDA by SimpleDocs
Production and Manufacturing. DWM represents and warrants to West Marine that DWM: A. Will be responsible for the timely production, manufacturing, and quality control of all of the West Marine Brand Apparel in accordance with the Specifications; B. Will Manufacture the West Marine Brand Apparel in a good and workmanlike manner and will comply with all applicable U.S. federal, state and local laws, ordinances and regulations, as well as all laws of the country in which the West Marine Brand Apparel will be manufactured, including all import and export laws and regulations. In this regard, DWM will utilize its best efforts to not use any cutting, sewing or other contractors, manufacturers or distributors that abuse U.S. Child Labor or other employment standards or laws; C. Will inspect and approve the finished product before shipment to the United States or other DWM or West Marine designated locations and such approval will be granted only if the West Marine Brand Apparel: conforms to Specifications, including all quality assurance standards; meets the requirements of all applicable laws and regulations; is packaged, labeled, priced and invoiced in accordance with the Specifications (and/or as specified in the SVA); and is executed according to the practices and regulations of the country of exportation; D. Will issue inspection certificates or return the West Marine Brand Apparel and process claims against the manufacturer(s) for product that fails to meet the Specifications. In the case of claims resulting from any defective or rejected West Marine Brand Apparel (including, without limitation, defects discovered after receipt and resale by West Marine), DWM will reimburse West Marine therefore * *; and E. Will use its best efforts to make quality products with quality workmanship: that all materials used in the manufacturing process will be new, in accordance with legal requirements, and of good and merchantable quality; that each product delivered to West Marine will, at the time of delivery, be free of defects; and that West Marine will receive good title to it free of all liens, and encumbrances of any kind. 5. Ordering: A. * * B. * * C. Nothing In this Agreement is intended to create any duty on the part of West Marine to place any Purchase Order or Assortment Approval letter or on the part of DWM to accept any Purchase Order or Assortment Approval letter, it being expressly understood that the placement of any such Purchase Order or Assortment Approval letter may be revoked and ...
Production and Manufacturing. Source: Department of Cottage and Small Industry, MoEA, Thimphu
Production and Manufacturing. The Contractor shall manufacture, test and deliver a low volume, high reliability system in a cost effective Manufacturing Plan (CDRL A082). Producibility shall be considered in all design decisions and shall incorporate continuous process improvement in development of manufacturing processes. The Contractor shall conduct in-house Manufacturing Readiness Assessments (MRAs) with program office participation using the definitions, criteria, and processes defined in the DoD Manufacturing Readiness Level (MRL) Deskbook (Attachment 13). MRAs shall be presented at PDR, CDR, and PRR and a MRA Report (CDRL A083) submitted for Government approval. The Contractor shall flow down on to and lead MRAs at major suppliers. For the purposes of this contract, a “major subcontractor” is defined as one subcontract with a total proposed amount of $2,000 ,000 or more, or 10% of total contract price, whichever is less, including options. The Contractor shall develop and implement manufacturing maturation plans for areas in which the Manufacturing Readiness Level (MRL) is lower than required to meet Milestone C. The Contractor shall monitor and provide status at all program reviews for in-house and major supplier MRLs and shall re-assess MRLs in areas for which design and process changes have occurred which could impact the MRL. Deliverables: Manufacturing Plan (CDRL A082) Manufacturing Readiness Assessment Report – MRA Report (CDRL A083) 18.2 PACKAGING, HANDLING, STORAGE, AND TRANSPORTATION (PHS&T) In addition to supporting the MK 48 MOD 7 APB6/TI-1 ILS IPT, the Contractor shall work with the ILS IPT during the planned approach and assessment of packaging options. MK 759 Mod 0 G&C Section Group I Shipping Containers (P/N 6146776) will be provided to the Contractor as GFE in quantities sufficient to support yearly planned MK 48 MOD 7 APB6/TI-1 G&C Section deliveries. MK 751 Mod 0 Metal Drum 6558374 WES container will be provided to the Contractor as GFE in quantities sufficient to support yearly planned MK 48 MOD 7 APB6/TI-1 WES Kit deliveries. Existing Torpedo All-Up-Round (AUR) container and G&C Section container configurations shall not be impacted by new hardware implementation. The Contractor shall assess the need to modify existing or design new containers to accommodate new or modified, GCBs, and Receivers. The Contractor’s findings shall be provided to the Government to determine if container development and fabrication is necessary. The Contractor shall develop and deli...

Related to Production and Manufacturing

  • Manufacturing (a) The Supplier shall without limitation be responsible, at no additional cost to the Purchaser, for: sourcing and procuring all raw materials for the Products; obtaining all necessary approvals, permits and licenses for the manufacturing of the Products; providing sufficient qualified staff and workers to perform the obligations under this Purchase Agreement; implementing and maintaining effective inventory and production control procedures with respect to the Products; and handling other matters as reasonably requested by the Purchaser from time to time.

  • Manufacture 2.1. The LED(s) on the LED module shall be equipped with suitable fixation elements.

  • Development of Products (a) During the term of this Agreement, ViewRay may from time to time seek services from PEKO with respect to the development of certain Products that can be incorporated into the ViewRay Renaissance™ MRI-guided radiation therapy system. For each Program to be undertaken by PEKO pursuant to this Agreement, the parties will prepare a “Work Statement” and agree to said “Work Statement” in substantially the form attached as Attachment 1. Each Work Statement will describe: (i) the (i) services that PEKO will be responsible for providing to ViewRay and the deliverables that PEKO will be responsible for delivering to ViewRay (“Deliverable(s)”), (ii) delivery schedule for the Deliverables, (iii) pricing terms, (iv) work plan for the Program, and (v) ViewRay’s responsibilities in connection with the Program. Each Work Statement will be prepared based upon the requirements and information provided to PEKO by ViewRay. A separate Work Statement will be required for each Program; and each Work Statement will become subject to this Agreement only when mutually agreed and signed by ViewRay and PEKO.

  • Manufacturing Services Jabil will manufacture the Product in accordance with the Specifications and any applicable Build Schedules. Jabil will reply to each proposed Build Schedule that is submitted in accordance with the terms of this Agreement by notifying Company of its acceptance or rejection within three (3) business days of receipt of any proposed Build Schedule. In the event of Jabil’s rejection of a proposed Build Schedule, Jabil’s notice of rejection will specify the basis for such rejection. When requested by Company, and subject to appropriate fee and cost adjustments, Jabil will provide Additional Services for existing or future Product manufactured by Jabil. Company shall be solely responsible for the sufficiency and adequacy of the Specifications [***].

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Manufacture of Products All Products marketed through Grantor's Web ------------------------- Site shall be manufactured, packaged, prepared, and shipped in accordance with the specifications and requirements described on Exhibit A hereto as it may be modified from time to time. Quality control standards relating to the Product's weight, color, consistency, micro-biological content, labeling and packaging are also set forth on Exhibit A. In the event that Exhibit A is incomplete, Products shall be manufactured and shipped in accordance with industry standards.

  • Manufacture of Product Prior to commercialization of the Product, the Parties may, if appropriate for both parties, negotiate in good faith a manufacturing and supply agreement to provide for Licensor to fulfill the manufacturing requirements of Licensee for Product for sale in the European market. The cost of such manufacturing shall not be greater than * percent (*%) of the cost of any competitor cGMP contract manufacturing facility that proposes to manufacturer the Product for Licensee. * Confidential information has been omitted and filed confidentially with the Securities and Exchange Commission.

  • Manufacturing Costs Patheon shall be allowed to adjust the Fees: (i) for costs associated with the conversion of Granulations and Components into Drug Product (the “Conversion Costs”) in respect of the Drug Product based on the most recently available final Producers’ Price Index for Pharmaceutical Product as published by the U.S. Bureau of Labor Statistics or any governmental successor thereto (“PPI”) using the procedure set forth in Section 4.3 and (ii) for Component Costs to pass on the actual amount of any increase or decrease in such costs without xxxx-up. For each Contract Year in which Patheon is entitled to adjust the Fees Patheon shall provide Client with written notice of any change in the Fees within 30 days of receipt by Patheon of the Annual Forecast. The Parties agree that the Fees shall not be adjusted more than once per Contract Year, however this limitation shall not include price adjustments under section 4.3 or 4.4. In addition, notwithstanding anything herein to the contrary, Manufacturing Fees associated with Conversion Costs shall not be increased by greater than [***]% per annum in any Contract Year during the Term. There shall be no similar limitation in terms of increases in Component Costs which shall be passed on to Client in an amount equal to the actual increase paid by Patheon without markup.

  • Commercialization Activities Within North America, the Parties will use Commercially Reasonable Efforts to Commercialize Licensed Products in the Field. In addition, within North America and subject to Section 2.7.6, the Parties will use Commercially Reasonable Efforts to conduct the Commercialization activities assigned to them pursuant to the Commercialization Plan/Budget, including the performance of detailing in accordance therewith. In conducting the Commercialization activities, the Parties will comply with all Applicable Laws, applicable industry professional standards and compliance policies of Celgene which have been previously furnished to Acceleron, as the same may be updated from time to time and provided to Acceleron. Neither Party shall make any claims or statements with respect to the Licensed Products that are not strictly consistent with the product labeling and the sales and marketing materials approved for use pursuant to the Commercialization Plan/Budget.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection xxxxx; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

Time is Money Join Law Insider Premium to draft better contracts faster.